DRUG-DEVICE COMBINATION PRODUCT MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-10904 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Drug-Device Combination Product Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL DRUG-DEVICE COMBINATION PRODUCT MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL DRUG-DEVICE COMBINATION PRODUCT MARKET
7.1 GLOBAL DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCT MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Abbott Laboratories
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Medtronic plc
16.3 Smith & Nephew plc
16.4 Boston Scientific Corporation
16.5 GlaxoSmithKline plc
16.6 Becton, Dickinson and Company
16.7 Johnson & Johnson
16.8 Novartis AG
16.9 Bayer AG
16.10 Baxter International, Inc.
16.11 Teva Pharmaceutical Industries Ltd.
16.12 AbbVie Inc.
16.13 SINOMED
16.14 Alcon Inc.
16.15 Teleflex Incorporated
16.16 Bausch Health Companies Inc.
16.17 Haselmeier GmbH
16.18 Flowonix Medical, Inc.
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By ProductDrug-eluting stent    
   o Coronary drug-eluting stent
   o Peripheral drug-eluting stent
Infusion pump
   o Implantable infusion pump
   o Insulin infusion pump
   o Patient-controlled analgesia pump
   o Ambulatory infusion pump
Photodynamic therapy
Antimicrobial wound dressing
Prefilled syringe
  o Single-chamber prefilled syringe
  o Dual-chamber prefilled syringe
  o Customized prefilled syringe
Drug-eluting balloon
  o Coronary drug-eluting balloon    
  o Peripheral drug-eluting balloon
Nebulizer
Inhaler
  o Drug powder inhaler (DPI)
  o Metered dose inhaler (MDI)
  o Soft mist inhaler (SMI)
Transdermal delivery system
  o Passive delivery system
  o Active delivery system
Other drug device combination products
By Application 
Cardiovascular disease
Diabetes
Respiratory problem
Cancer treatment
Antimicrobial application
Other applications
By End User
Hospital & clinic
Ambulatory surgery center (ASC)
Home care setting
Other end users
Companies
Abbott Laboratories
Medtronic plc
Smith & Nephew plc
Boston Scientific Corporation
GlaxoSmithKline plc
Becton, Dickinson and Company
Johnson & Johnson
Novartis AG
Bayer AG
Baxter International, Inc.
Teva Pharmaceutical Industries Ltd.
AbbVie Inc.
SINOMED
Alcon Inc.
Teleflex Incorporated
Bausch Health Companies Inc.
Haselmeier GmbH
Flowonix Medical, Inc.
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.